BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo